Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
26-Dec-25 A- A2 Stable Maintain -
27-Dec-24 A- A2 Stable Maintain -
28-Dec-23 A- A2 Stable Initial -
About the Entity

Dr. Ziauddin Hospital Trust (DZHT) is a leading private healthcare institution in Pakistan, operating a multi-campus hospital network across North Nazimabad, Clifton, Kemari, and Sukkur. Established in 1975, the Trust provides tertiary and quaternary healthcare services across a wide range of medical specialties. The Trust is governed by a six-member Board of Trustees. Mr. Asim Hussain is serving as the Chief Trustee. DZHT is affiliated with Ziauddin University, supporting clinical excellence through medical education and research.

Rating Rationale

The assigned ratings reflect Dr. Ziauddin Hospital Trust’s (“DZHT” or “the Trust”) positioning as one of Pakistan’s prominent private healthcare institutions, underpinned by its established brand legacy, multi-campus footprint, and its integral role in delivering tertiary and quaternary healthcare services. The Trust operates under a not-for-profit framework in accordance with the Sindh Trust Act, 2020, which provides significant fiscal advantages through tax exemptions and enhances financial flexibility. DZHT’s long-standing association with Ziauddin University further reinforces its institutional strength, ensuring a steady pipeline of skilled medical professionals and supporting clinical research, supplemented by academic excellence. Following the operationalization of the 5th floor at the Clifton campus and the addition of the 180-bed Sukkur campus, the Trust’s total capacity has increased to around 900 beds. The Sukkur facility has surpassed its breakeven point and is now contributing positively to overall profitability. In parallel, the Trust has invested in advanced diagnostics, including the installation and commissioning of Cyclotron and PET-CT facility, enabling in-house isotope production for oncological diagnostics and strengthening the hospital’s position in high-end cancer care.
During FY25, the topline of the trust enhanced by 33.4% clocking at PKR 12.9bln (FY24: PKR 9.6bln), supported by diversified revenue streams across pharmacy, laboratory, radiology, wards, and diagnostic services. However, the net margin remained modest due to the impact of deferred taxation adjustments, which compressed profitability despite operational performance. Energy optimization initiatives, including solar installations across Clifton, Kemari, and Sukkur campuses, resulted in cost savings of approximately PKR 100mln, partially mitigating inflationary and utility cost pressures.
The financial risk profile of the trust is considered adequate with a low leveraged capital structure. Total borrowings stood at PKR 3.3bln (FY24: PKR 2.6bln), translating into a total leverage of around 31.3% (FY24: 29.0%). Liquidity is adequately supported by internal cash generation, with FCFO increasing to PKR 1.6bln. Coverage indicators have improved, with EBITDA-to-finance cost rising to 4.1x, reflecting improved operational cash flows and lower interest rates during the year. Going forward, leverage metrics are expected to be elevated moderately due to the planned initiative of an Islamabad-based hospital project, financed primarily through long-term debt with a structured grace period to support cash flow stability during the initial phase.

Key Rating Drivers

The ratings are dependent upon the management’s ability to capitalize on growth opportunities in a competitive landscape, operate at an optimum level, and improve margins and coverage. Going forward, adherence to the debt matrix at an adequate level is a prerequisite for the assigned ratings.

Profile
Legal Structure

Dr. Ziauddin Hospital Trust ("DZHT" or "the Trust") is a not-for-profit organization established in Pakistan through a Declaration of Trust executed on August 10, 1976. The Trust is duly registered under the Sindh Trust Act, 2020. During the year, DZHT was granted Not-for-Profit Organization (NPO) status under Section 2(36)(c) of the Income Tax Ordinance, 2001, thereby affirming its tax-exempt status and compliance with applicable regulatory requirements for non-profit entities in Pakistan.


Background

The Dr. Ziauddin Group of Hospitals traces its origins to the 1950s with the establishment of Nazimabad Memorial Hospital, a 25-bed maternity facility founded by Dr. Aijaz Fatima, daughter of Sir Dr. Ziauddin Ahmed, and her late husband, Dr. Tajamul Hussain. This initiative laid the foundation for the Group’s development in the healthcare sector. Subsequently, Dr. Ziauddin Hospital was formally established in North Nazimabad in 1975, initially operating as a small maternity home. Over the years, the institution has expanded into a multi-campus hospital network comprising facilities in North Nazimabad, Clifton, Kemari, and Sukkur, providing secondary, tertiary, and quaternary healthcare services across a broad range of medical specialties.


Operations

DZHT operates a comprehensive multi-campus healthcare network spanning Karachi and Sukkur, with major facilities in North Nazimabad, Clifton, Keamari, and Sukkur, complemented by outreach centers including Dr. Ziauddin Cancer Hospital, Dr. Ziauddin Memorial Hospital, and Boat Basin Executive Clinics. The Trust's primary objective is to establish and operate hospitals for the sick while providing relief of a charitable nature at reasonable costs. The Trust delivers tertiary and quaternary healthcare services with a combined bed capacity of approximately 900 beds, offering a full spectrum of medical care that encompasses outpatient consultations, emergency services, inpatient treatment, surgical procedures, and critical care. The Head Office is located at Street No. 6, Block B, North Nazimabad, Karachi.


Ownership
Ownership Structure

Dr. Ziauddin Hospital operates under the legal framework of a trust, formally registered as the Dr. Ziauddin Hospital Trust. The trust holds full ownership of the hospital and its associated institutions, ensuring that all assets and operations are managed in accordance with its objectives.


Stability

The ownership structure of Dr. Ziauddin Hospital Trust remains stable and well-entrenched, supported by the longstanding presence of the Ziauddin Group and its institutional trust-based framework. The Group’s diversified presence across healthcare and education further enhances ownership stability and reduces contagion risk.


Business Acumen

Dr. Asim Hussain serves as the Chairman of the Group, recipient of Sitara-e-Imtiaz and Nishan-e-Imtiaz for his contributions to education and healthcare. His distinguished career includes serving as Chairman of the National Reconstruction Bureau (Federal Minister status), Chairman of Sindh Higher Education Commission (2014, reappointed 2018), and Honorary Personal Physician to the President of Pakistan (2009). Under his leadership, the Group has evolved from a single facility into a diversified network of hospitals and a chartered university, with a commitment to quality, transparency, and continuous improvement supporting long-term growth prospects.


Financial Strength

The financial strength of Dr. Ziauddin Hospital is underpinned by its strategic integration within the Ziauddin Group alongside Ziauddin University. This integrated structure creates a synergistic model that enables consistent reinvestment in advanced medical technology and infrastructure development. The institutional framework provides a strong foundation for sustained financial resilience and supports the Hospital's long-term growth trajectory.


Governance
Board Structure

The Trust operates under a six-member Board of Trustees, comprising five executive directors and one non-executive director. The Board is led by Mr. Asim Hussain, who serves as Chief Trustee. The Board provides effective oversight and strategic direction, ensuring sound decision-making while upholding best practices across their respective areas of responsibility.


Members’ Profile

The Board members possess significant collective expertise in the healthcare sector, bringing diverse professional backgrounds and specialized qualifications. Dr. Asim Hussain serves as Chairman and Trustee of Dr. Ziauddin Hospital Trust and Chancellor of Ziauddin University, Karachi. A prominent figure in healthcare and education, he has been instrumental in the expansion and institutionalization of the Ziauddin Group. He holds an MBBS from Dow Medical College, a D. Ortho from Vienna, Austria, following postgraduate training in orthopaedics in Europe, and an MS in Surgery from Ziauddin University. He is a Member of the College of Physicians and Surgeons Pakistan (CPSP). In 1995, he established Ziauddin University, which is chartered by the Government of Sindh and recognized by the Higher Education Commission (HEC) of Pakistan.
Dr. Ammad Hussain serves as Chief Executive and Trustee. He holds an MBChB from the University of Birmingham, UK, and completed his radiology training at King's College Hospital, London, followed by a fellowship in Interventional Radiology from Barts Health NHS Trust. He has served as a consultant in the UK's NHS and currently works as a part-time consultant with NHS England and the Dr. Ziauddin Hospital Group. Dr. Arif Hussain serves as Trustee and holds the position of Director (Laboratory) and Consultant Pathologist at Dr. Ziauddin Hospital. He is also an Associate Professor of Pathology at Ziauddin University. His qualifications include an MBBS from Dow Medical College, an MSc in Clinical Biochemistry (Molecular Biology) from the University of Surrey, UK, and a PhD from the University of Karachi. Dr. Nida Hussain serves as Pro-Chancellor of Ziauddin University, Trustee of Dr. Ziauddin Hospital Trust, and Chairperson of the Ziauddin Education System. She holds an MBBS from Dow University and is a Diplomate of the American Board of Internal Medicine from Mount Sinai, New York, USA. Belonging to the founding family of the Ziauddin Group, she carries forward the legacy of Sir Dr. Ziauddin Ahmad with a strong commitment to advancing healthcare and education.


Board Effectiveness

The Board demonstrates effective oversight through a balanced composition of executive and non-executive directors, ensuring diverse perspectives in strategic decision-making. Board meetings are convened regularly on a need basis, maintaining responsive governance aligned with operational requirements. Meeting agendas encompass comprehensive review areas including policies and procedures, products and services evaluation, and strategic planning discussions. This structured approach ensures that governance activities remain closely aligned with the Trust's operational needs and long-term strategic objectives, supporting informed decision-making and accountability across the organization.


Financial Transparency

BDO Ebrahim & Co., Chartered Accountants, are the external auditors of the Trust and are categorized under Category “A” of the State Bank of Pakistan’s panel of auditors. The auditors have expressed an unqualified opinion on the financial statements for the year ended June 30, 2025.


Management
Organizational Structure

The Trust maintains a lean organizational structure designed to ensure operational efficiency and effective communication across all levels. Operational staff report to the CEO and Managing Director through various management heads, creating clear reporting lines and accountability. The organizational framework is supported by functional committees responsible for overseeing operations and conducting regular assessments of internal controls, ensuring adherence to established policies and risk management protocols.


Management Team

The Trust's operations are led by an experienced management team with specialized expertise across healthcare administration, clinical operations, and organizational development. Mr. Osama Ahmad, Managing Director of Dr. Ziauddin Group of Hospitals, brings over 25 years of leadership experience across healthcare, education, and multiple industries. A Chartered Accountant with expertise in financial and operational planning, strategy, governance, and risk management, he focuses on technological advancement, transparency, and quality to drive patient care, sustainability, and growth. Dr. Ashar Ekhlaq Ahmed serves as Medical Director of Dr. Ziauddin Group of Hospitals and Director of Postgraduate Medical Education (Clinical) at Ziauddin University. A specialist Rheumatologist, he oversees clinical operations and ensures high standards of patient care. He previously served as Clinical Director of Medicine at Southport and Ormskirk NHS Trust, UK, and is a member of the Pakistan Society of Rheumatologists, British Rheumatology Society, and the Faculty of Medical Leadership and Management, UK.
Ms. Samina Naushin serves as COO – Head Office and Group Head of HR, bringing over 25 years of experience in organizational leadership and strategic HR management. She oversees hospital operations and leads HR initiatives across the group, focusing on workforce strategy, employee engagement, and operational efficiency. Ms. Sabina Khalid serves as COO of the Clifton Campus, overseeing comprehensive hospital operations. Initially joining as GM (HR & Administration) to strengthen HR policies and administrative functions, she now focuses on process optimization, patient care enhancement, and overall operational efficiency. Dr. Arbas Waleed serves as COO of the Sukkur Campus, bringing over 14 years of experience in healthcare operations and strategic management. He focuses on optimizing hospital operations, ensuring high-quality patient care, and enhancing efficiency through effective resource and cost management.


Effectiveness

The management team exercises comprehensive oversight of daily operations while ensuring adherence to established quality standards. Department heads are responsible for both operational efficiency and quality assurance, maintaining a dual focus on smooth execution and excellence in service delivery. This integrated approach ensures that departmental activities are completed efficiently while consistently meeting the organization's defined standards of quality and performance.


MIS

DZHT operates an integrated technology framework to support clinical and administrative operations. A comprehensive Hospital Management Information System (HMIS) manages patient care functions including patient registration, emergency services, pharmacy operations, and other clinical areas. Financial operations, billing, and supply chain management are handled through Oracle ERP, which is fully integrated with the HMIS to ensure seamless data flow across systems. To enhance business continuity, security, and operational efficiency, the Trust has implemented Hyper Converged Infrastructure (HCI) alongside other IT controls and applications, providing a robust and secure technology environment for critical hospital operations.


Control Environment

DZHT holds multiple national and international certifications, reflecting its commitment to quality healthcare and patient safety. The hospital is licensed and regulated by the Sindh Healthcare Commission (SHCC), ensuring compliance with provincial healthcare standards. Its clinical laboratories are certified with ISO 15189 and by the Pakistan National Accreditation Council (PNAC), confirming adherence to international and national standards in laboratory quality and competence. Additionally, DZHT has achieved ISO 9001:2015 certification for quality management systems across its campuses. The Trust regularly undergoes surveillance audits and licence renewals, demonstrating sustained compliance with regulatory and quality benchmarks, and reinforcing its reputation as a leading healthcare provider in Pakistan.


Business Risk
Industry Dynamics

According to the Economic Survey of Pakistan 2024–25, Pakistan's public health expenditure reached approximately PKR 925bln for FY2024–25. Despite a year-on-year increase in total outlays, this represents less than 1% of GDP. The healthcare workforce has experienced expansion, with the number of registered doctors increasing to nearly 319,000 and dentists to over 39,000. This professional base is supported by approximately 138,000 nursing personnel, 46,801 midwives, and 29,000 lady health workers. The physical infrastructure comprises around 1,696 hospitals and 5,434 Basic Health Units (BHUs) nationwide, reflecting modest growth in healthcare facilities. Despite these developments, the sector continues to face significant challenges. Critical doctor-to-population ratios persist, alongside substantial gaps in service delivery between urban and rural areas. Key operational constraints include reputational risks, capacity and infrastructure development requirements, quality-of-care standards, and the high costs associated with imported medical equipment and consumables. Additionally, the sector contends with elevated energy requirements that further strain operational efficiency.


Relative Position

The hospital industry in Pakistan operates within a highly fragmented landscape characterized by numerous independent providers and limited market concentration. Within this competitive environment, Dr. Ziauddin Hospital Trust maintains a significant presence with an operational capacity of around 900 beds across its network. This bed capacity positions the Trust among the larger healthcare providers in the country, reflecting an adequate market share within Pakistan's hospital sector.


Revenues

During FY25, the topline of the trust enhanced by 33.4% clocking at PKR 12.9bln (FY24: PKR 9.6bln), supported by diversified revenue streams across pharmacy, laboratory, radiology, wards, and diagnostic services. Revenue generation is concentrated across two main campuses: North Nazimabad (Head Office) leads with a 45% contribution, while Clifton follows closely at 44%. The remaining 11% is collectively contributed by the Kemari and Sukkur campus. In terms of payment composition, 63% of revenue is derived from direct patient payments (cash and credit card), while the remaining 37% originates from corporate client agreements.


Margins

As of FY25, the Trust’s margins remained under pressure despite strong revenue growth. The gross margin declined to 16.9% (FY24: 17.8%) due to escalating input costs, higher energy expenses, and upward revisions in wage rates. While the operating margin improved to 10.1% (FY24: 7.6%) on the back of better cost absorption from higher volumes. However, the net margin moderated to 1.8% (FY24: 2.6%), due to the impact of deferred taxation adjustments, which compressed profitability despite operational performance.


Sustainability

The Trust is actively pursuing strategic expansion initiatives to enhance capacity and geographic reach. The flagship project involves the development of a healthcare facility in Islamabad, for which 20 acres of land have been acquired and architectural designs finalize. At the Clifton campus, following the successful operationalization of the 5th floor, the grey structure for the 6th floor has been completed. Additionally, management has planned the construction of two additional floors at the North Nazimabad campus to accommodate rising healthcare demand in the catchment area and enhance operational capacity. These expansion initiatives reflect the Trust's commitment to scaling infrastructure in line with growing service delivery requirements.


Financial Risk
Working capital

In FY25, net working capital days increased to 22 days (FY24: 13 days), primarily driven by a decrease in trade payable days, which contracted to 48 days (FY24: 57 days), while gross working capital days remained stable at 70 days (FY24: 70 days). To fuel its working capital requirements, the trust relies on a mix of short-term borrowings and internally generated cashflows. The current ratio improved slightly to 1.2x (FY24: 1.1x), indicating adequate short-term liquidity. 


Coverages

During FY25, the Trust’s coverage indicators strengthened, underpinned by improved operating performance and robust cash flow generation. Free cash flow from operations (FCFO) increased to PKR 1,579mln (FY24: PKR 971mln), reflecting a strong growth of 62.5%, which enhanced the Trust’s liquidity position. The interest coverage ratio improved to 4.1x (FY24: 2.6x), indicating a more comfortable ability to meet debt obligations.


Capitalization

DZHT maintains a relatively low-leverage capital structure, with total borrowings accounting for 31.3% of total capitalization in FY25 (FY24: 29%). Short-term borrowings represent approximately 25.8% of total debt, indicating a moderate reliance on short-term financing to meet liquidity requirements. The Trust’s equity base remains the primary source of funding, totaling PKR 8,073mln in FY25 (FY24: PKR 7,561mln), supported by capital and revenue reserves. Over the years, DZHT has gradually increased its leverage to support expansion and capital expenditure, while maintaining a robust equity buffer to safeguard financial stability.


 
 

Dec-25

www.pacra.com


Jun-25
12M
Jun-24
12M
Jun-23
12M
A. BALANCE SHEET
1. Non-Current Assets 10,030 9,365 8,457
2. Investments 12 50 55
3. Related Party Exposure 1,149 1,055 589
4. Current Assets 3,786 3,030 2,588
a. Inventories 776 614 500
b. Trade Receivables 2,098 1,423 1,156
5. Total Assets 14,977 13,500 11,689
6. Current Liabilities 3,197 2,788 1,809
a. Trade Payables 1,648 1,743 1,270
7. Borrowings 3,330 2,587 1,919
8. Related Party Exposure 342 502 589
9. Non-Current Liabilities 35 62 61
10. Net Assets 8,073 7,561 7,310
11. Shareholders' Equity 8,073 7,561 7,310
B. INCOME STATEMENT
1. Sales 12,859 9,639 7,960
a. Cost of Good Sold (10,691) (7,928) (6,937)
2. Gross Profit 2,168 1,711 1,023
a. Operating Expenses (865) (975) (417)
2. Operating Profit 1,303 737 606
a. Non Operating Income or (Expense) 32 157 64
3. Profit or (Loss) before Interest and Tax 1,335 894 670
a. Total Finance Cost (495) (503) (287)
b. Taxation (604) (141) (78)
4. Net Income Or (Loss) 237 250 305
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 1,579 971 879
b. Net Cash from Operating Activities before Working Capital Changes 1,117 472 633
c. Changes in Working Capital (519) 12 (251)
1. Net Cash provided by Operating Activities 598 485 381
2. Net Cash (Used in) or Available From Investing Activities (1,238) (783) (1,318)
3. Net Cash (Used in) or Available From Financing Activities 252 651 823
4. Net Cash generated or (Used) during the period (388) 353 (115)
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) 33.4% 21.1% 13.0%
b. Gross Profit Margin 16.9% 17.8% 12.9%
b. Net Profit Margin 1.8% 2.6% 3.8%
c. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) 8.2% 10.2% 7.9%
d. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 3.0% 3.4% 4.3%
2. Working Capital Management
a. Gross Working Capital (Average Days) 70 70 68
b. Net Working Capital (Average Days) 22 13 11
c. Current Ratio (Current Assets / Current Liabilities) 1.2 1.1 1.4
3. Coverages
a. EBITDA / Finance Cost 4.1 2.6 4.2
b. FCFO / Finance Cost+CMLTB+Excess STB 1.0 0.7 1.2
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 2.7 5.6 3.6
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 31.3% 29.0% 25.5%
b. Interest or Markup Payable (Days) 25.3 12.2 17.7
c. Entity Average Borrowing Rate 14.3% 17.2% 11.9%

Dec-25

www.pacra.com

Dec-25

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

Dec-25

www.pacra.com